Faculty

Institution

Unit

Venue

Omeed Moaven

Louisiana State University Health Sciences Center, New Orleans

Affiliations

Department Of Colon And Rectal Surgery

School of Medicine

Department Of Interdisciplinary Oncology

Department Of Surgery And Cardio-Vascular Outcomes Research Group

Division Of Cardiothoracic Surgery

Division Of Neuroendocrine Surgery And Transplantation

Division Of Vascular Surgery

Louisiana State University Health Sciences Center, New Orleans

School of Graduate Studies

NoneOmeed Moaven is currently serving as a Colon And Rectal Surgery faculty at Louisiana State University Health Sciences Center, New Orleans.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Omeed Moaven

Louisiana State University Health Sciences Center, New Orleans

You can click a keyword to filter the displayed items

oncology surgical oncology surgery cancer care cancer research radiation oncology outcomes research gastrointestinal surgery medicine pancreatic cancer metastasis liver cancer immunology gastroenterology cancer immunotherapy cancer treatment gastrointestinal oncology immunotherapy cellular therapy colorectal cancer pancreatitis thoracic oncology tumor targeting pancreatic surgery colorectal liver metastases liver transplantation liver physiology digestive endoscopy cancer imaging medicinal research cancer management colorectal surgery hyperthermic intraperitoneal chemotherapy peritoneal surface malignancies healthcare disparities medical mycology medical virology virus research biomedical analysis perioperative care genitourinary cancers disease progression hepatobiliary tumors digestive system surgery patient-reported outcomes synthetic virology pancreatic fluid collection oncolytic virotherapy transplantation proceeding antiviral research cancer biology treatment development transfusion medicine personalized treatments clinical practice cancer-associated virus antiviral drugs antiviral drug development disease gene identification cytogenetics cancer genetics genomic medicine medical genetics liver disease postoperative consideration major therapeutic barrier resectable pancreatic cancer cytoreductive surgery/hipec health-related quality mucinous appendiceal cancer 30-year institutional experience repeat cytoreductive surgery potent oncolytic viruses clinical implications genetic signatures appendiceal cancer patients

Notable Scholarly Works

Notable Federal Grants

Collaborators

Cmtm6-Silencing Microbial Immunotherapy Reprograms Pdac Tumors and Restores T-Cell Function. bioRxiv (Cold Spring Harbor Laboratory) (2026)

restores t-cell functioncancer immunotherapyimmunologycell biologycell transplantationimmunotherapycellular therapyimmunomodulationimmune responsescancer immunosurveillancecancer cellscell researchtherapeutic vaccinestumor microenvironment

Comparative Proteomic Profiling of Responses to Standard Systemic Treatment Regimens in Pancreatic Cancer. Cells (2026)

oncogenespathologyprognostic biomarkerstranslational proteomicscomparative proteomic profilingcell biologymolecular cancercancer researchmolecular diagnosticspancreatic cancerclinical proteomicsbiomarkerscancer cellscancer genomics

Does Prophylactic Intraperitoneal Chemotherapy Provide Any Clinical Benefit After Curative Colorectal Cancer Resection?. Annals of Surgical Oncology (2026)

Outcomes of Total Pancreatectomy Versus Pancreaticoduodenectomy for Surgical Management of Pancreatic Ductal Adenocarcinoma. Journal of Surgical Oncology (2026)

Abstract 947: Engineering a Synthetic Oncolytic Virus to Overcome Apoptotic Resistance and Induce Immunogenic Cell Death in Pancreatic Ductal Adenocarcinoma. Cancer Research (2025)

Aleksandra CiosKhandoker Usran FerdousMulu Z. TesfayAlicja UrbaniakBahaa MustafaSteven R. PostThomas J. KellyMartin J. CannonAlexei BasnakianOmeed MoavenBolni Marius Nagalo

immunogenic cell deathapoptotic resistancesynthetic biologypancreatic ductal adenocarcinomacancer researchsynthetic oncolytic virusbiomolecular engineeringsynthetic virology

Abstract B022: Reprogramming Apoptotic Resistance in Pdac Through Synthetic Oncolytic Immunotherapy. Cancer Research (2025)

abstract b022cancer immunotherapyimmunologycell biologymedicinal researchimmunotherapycellular therapynovel therapiesreprogramming apoptotic resistanceimmune responsesimmune checkpoint inhibitorssynthetic immunology

Decision to Operate on Hepatocellular Cancer Patients is Not Driven by Comorbidities in Louisiana. HPB (2025)

health services researchpublic healthhealth careliver cancersurgical oncologyhepatologycancer disparitieshepatocellular cancer patientsoutcomes researchcancer researchhealth systemsmedicinehepatocellular carcinomacancer careoncology

Disparities in Access to Care in the Multimodal Treatment of Primary Nonmetastatic Liver Cancers and Their Impact on Patient Outcomes. Journal of Surgical Oncology (2025)

health policytheir impacthealth careliver cancerpatient outcomessurgical oncologyhepatologycancer disparitiesoutcomes researchpatient-reported outcomesmultimodal treatmentfamily medicinecancer careoncology

Evaluating the Impact of Medicaid Expansion on Outcomes for Patients With Gastric Cancer in Louisiana.. Journal of Clinical Oncology (2025)

Massive Msv000100320 - Proteomic Profiling of Responses to Standard Systemic Treatment Regimens in Pancreatic Cancer. (2025)

1
2
3
4
5
6
7
10 / page

Omeed Moaven

Louisiana State University Health Sciences Center, New Orleans

Affiliations

Department Of Colon And Rectal Surgery

School of Medicine

Department Of Interdisciplinary Oncology

Department Of Surgery And Cardio-Vascular Outcomes Research Group

Division Of Cardiothoracic Surgery

Division Of Neuroendocrine Surgery And Transplantation

Division Of Vascular Surgery

Louisiana State University Health Sciences Center, New Orleans

School of Graduate Studies

NoneOmeed Moaven is currently serving as a Colon And Rectal Surgery faculty at Louisiana State University Health Sciences Center, New Orleans.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Omeed Moaven

Louisiana State University Health Sciences Center, New Orleans

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Cmtm6-Silencing Microbial Immunotherapy Reprograms Pdac Tumors and Restores T-Cell Function. bioRxiv (Cold Spring Harbor Laboratory) (2026)

Comparative Proteomic Profiling of Responses to Standard Systemic Treatment Regimens in Pancreatic Cancer. Cells (2026)

Does Prophylactic Intraperitoneal Chemotherapy Provide Any Clinical Benefit After Curative Colorectal Cancer Resection?. Annals of Surgical Oncology (2026)

Outcomes of Total Pancreatectomy Versus Pancreaticoduodenectomy for Surgical Management of Pancreatic Ductal Adenocarcinoma. Journal of Surgical Oncology (2026)

Abstract 947: Engineering a Synthetic Oncolytic Virus to Overcome Apoptotic Resistance and Induce Immunogenic Cell Death in Pancreatic Ductal Adenocarcinoma. Cancer Research (2025)

Aleksandra CiosKhandoker Usran FerdousMulu Z. TesfayAlicja UrbaniakBahaa MustafaSteven R. PostThomas J. KellyMartin J. CannonAlexei BasnakianOmeed MoavenBolni Marius Nagalo

immunogenic cell deathapoptotic resistancesynthetic biologypancreatic ductal adenocarcinomacancer researchsynthetic oncolytic virusbiomolecular engineeringsynthetic virology

Abstract B022: Reprogramming Apoptotic Resistance in Pdac Through Synthetic Oncolytic Immunotherapy. Cancer Research (2025)

Decision to Operate on Hepatocellular Cancer Patients is Not Driven by Comorbidities in Louisiana. HPB (2025)

Disparities in Access to Care in the Multimodal Treatment of Primary Nonmetastatic Liver Cancers and Their Impact on Patient Outcomes. Journal of Surgical Oncology (2025)

Evaluating the Impact of Medicaid Expansion on Outcomes for Patients With Gastric Cancer in Louisiana.. Journal of Clinical Oncology (2025)

Massive Msv000100320 - Proteomic Profiling of Responses to Standard Systemic Treatment Regimens in Pancreatic Cancer. (2025)

1
2
3
4
5
6
7
10 / page